Developer docs
API playgroundTry for free, no card

Search company profiles

Dynamic42

Full company profile

uuid0007ufg

Namestring
Dynamic42
Legal namestring
Dynamic42 GmbH
Websiteurl
dynamic42.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Dynamic42 GmbH is a German biotechnology company founded in 2018 as a spin-off from the Integrated Research and Treatment Center for Sepsis Control and Care (CSCC) at the University Hospital Jena. The company develops and commercializes immunocompetent organ-on-chip (microfluidic biochip) in vitro test systems that replicate key functions of human organs, including vasculature, immune cells, microbiome, and pathogens, for preclinical drug testing, toxicology, and disease modeling applications.

The company's core platform is the DynamicOrgan® System, a modular organ-on-chip architecture featuring biochips with low compound adsorption, integrated pumps, and a portfolio of add-on kits: 2-Channel, 3-Channel, Spheroid, Tumor Microenvironment (TME), TEER-Sensor (embedded gold electrodes for barrier integrity), and O2-Sensor (developed with PyroScience) kits. The platform supports multiple organ models (gut, liver, lung, vasculature, cancer, spheroid) and multi-organ configurations such as gut-liver axis. Manufacturing and services operate under ISO 9001 and ISO 13485 quality standards, and Dynamic42 is a founding member of IAMPS, Europe's first industry association for microphysiological systems providers.

Dynamic42 generates revenue through three streams: (1) hardware sales of the DynamicOrgan System and modular kits, (2) fee-for-service Contract Research (CRO) offerings including toxicology screenings, lead identification/optimization, and custom in vitro model development, and (3) the Dynamic42 Academy training programs for organ-on-chip users. The customer base spans pharmaceutical and chemical companies (BASF, Sanofi via iDEA-iTECH Award, Bayer Consumer Health), academic and research institutions (Jena University Hospital, Leibniz-HKI, HZI Braunschweig, MLU Halle-Wittenberg, Freie Universität Berlin), and CROs. Distribution combines direct sales from Jena headquarters with regional distributors (Axon Lab AG for Central Europe, Ohio Lumex for the U.S./Canada) as the company expands internationally, including a planned U.S. market entry supported by a mid-seven-figure Series A round closed in June 2023.

Short descriptiontext

Dynamic42 GmbH develops and sells immunocompetent organ-on-chip platforms (DynamicOrgan® System) and provides contract research services to pharmaceutical, biotech, and academic customers for preclinical drug testing, toxicology, and human disease modeling.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersJena, Germany
HQ citystring
Jena
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
organ-on-chip technology, microphysiological systems, in vitro disease models, preclinical drug testing, biotech research tools
Industry2 codes
PRIMARYHLAAAGAD
Organoids & Organ-on-Chip (regenerative models)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Organ-on-chip Technology
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1DynamicOrgan System and Kits Sales
TypeHardware Sales
Description

Sale of the DynamicOrgan System platform, biochips, and various developer, sensor, and reagent kits including 2-Channel Kit, 3-Channel Kit, Spheroid Kit, TME Kit, TEER-Sensor Kit, and O2-Sensor Kit.

dynamic42.com
2Contract Research Services (CRO)
TypeProfessional Services
Description

Fee-for-service offerings including toxicology screenings, lead identification and optimization, and custom in vitro model development using the company's organ-on-chip platforms.

dynamic42.com
3Dynamic42 Academy Training
TypeProfessional Services
Description

On-site and online training courses through the Dynamic42 Academy for researchers wanting to integrate organ-on-chip technology into their lab work.

dynamic42.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1DynamicOrgan® System
Description

User-friendly organ-on-chip system with ISO-certified, medical-grade standards for creating diverse organ models including gut, lung, liver, vasculature, cancer, and spheroid-on-chip.

dynamic42.com
Core offering1 text field

Dynamic42 develops and sells the DynamicOrgan® System, an organ-on-chip (microfluidic biochip) platform with modular kits (2-Channel, 3-Channel, Spheroid, TME, TEER-Sensor, O2-Sensor) that recreate human organ functions including vascularization, immune cells, microbiome, and pathogens. The company also offers fee-for-service contract research (toxicology screenings, lead optimization, custom model development) and training via the Dynamic42 Academy to pharmaceutical, biotech, and academic customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Verifying recycling process of therapeutic antibodies without compromising cell viability or tissue integrity in liver-on-chip model
+2 more records
Product overview1 text field

Dynamic42 offers the DynamicOrgan® System as its core platform for organ-on-chip technology, accompanied by a modular kit portfolio including 2-Channel, 3-Channel, Spheroid, TME (Tumor Microenvironment), TEER-Sensor, and O2-Sensor kits. These kits are designed to work with the DynamicOrgan® System to create various organ models (Gut, Liver, Lung, Vasculature, Spheroid, Cancer-on-Chip). The platform is designed for immunocompetent infection and disease models with vascularization and organ-specific perfusion capabilities. The company also provides Contract Research Services for toxicology screenings, lead optimization, and custom model development, along with Dynamic42 Academy training programs.

Product and service10 records
1DynamicOrgan® System
CategoryCore platform
Description

Core organ-on-chip platform that enables physiological cell and tissue culture. The system includes biochips and a pump that integrate seamlessly into existing workflows for creating human disease and infection models with vascularization, immune cells, microbiome, and pathogens. Sold to pharmaceutical, biotech, and academic researchers.

2DynamicOrgan® 2-Channel Kit
CategoryBiochip kit
Description

Biochip kit with two channels for creating in vitro human disease and infection models in a dynamically perfused environment, sold separately to laboratories building organ-on-chip models.

3DynamicOrgan® 2-Channel Kit – precious
CategoryBiochip kit
Description

Specialized version of the 2-channel kit designed for working with precious or limited cell samples; sold as a standalone SKU.

4DynamicOrgan® 3-Channel Kit
CategoryBiochip kit
Description

Three-channel biochip kit that enables more complex multi-layer tissue models and co-culture setups, sold as a standalone product for advanced organ-on-chip applications.

5DynamicOrgan® Spheroid Kit
CategoryBiochip kit
Description

Kit designed for spheroid culture within the DynamicOrgan System, enabling 3D tumor and tissue model development. Sold to researchers building 3D spheroid-on-chip applications.

6DynamicOrgan® TME Kit
CategoryBiochip kit
Description

Tumor Microenvironment Kit for cancer research, enabling biomimetic matrix integration in 3-channel biochips for advanced cancer models with stromal and immune components.

7DynamicOrgan® TEER-Sensor Kit
CategoryBiochip kit
Description

Sensor kit enabling integrated Trans-Epithelial/Trans-Endothelial Electrical Resistance (TEER) measurement, with embedded gold electrodes for real-time, non-invasive barrier integrity monitoring within the biochip architecture.

8DynamicOrgan® O2-Sensor Kit
CategoryBiochip kit
Description

Sensor kit for real-time oxygen tracking in organ-on-chip models, developed in collaboration with PyroScience, enabling monitoring of oxygen levels experienced by cells in the microfluidic environment.

9Contract Research Services
CategoryContract research
Description

Fee-for-service contract research offerings including toxicology screenings, lead identification and optimization, and custom in vitro model development using Dynamic42's immune-competent organ models; offered directly to pharmaceutical, biotech, and chemical customers.

10Dynamic42 Academy
CategoryTraining
Description

Training program offering on-site and online courses for learning organ-on-chip technology, including chip handling, cell culture, and organ model development. Available to researchers integrating organ-on-chip technology into their laboratory work.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

Strategic collaboration to integrate organ-on-chip technologies into preclinical glioblastoma research. First joint projects target glioblastoma and blood-brain barrier (BBB) using Dynamic42's human-based BBB-on-chip model. The partnership includes model development, commercialization strategies, and scientific exchange between researchers from both organizations. Joint presentation at AACR Annual Meeting 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

World's first industry association dedicated to representing microphysiological systems providers across Europe. Founding member along with Alveolix, BiomimX, Chiron, InSphero, MIMETAS, NETRI, React4Life, and TissUse. IAMPS will work to increase regulatory acceptance of MPS data, create data-sharing platforms, and advance device standardization. Expected to become operational Q2 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-06
Description

Collaboration to develop tumour-on-chip model replicating pancreatic ductal adenocarcinoma (PDAC) microenvironment. Joint research with Prof. Dr. Nicole Teusch's team. Results published in Lab on a Chip journal. Model tested FDA-approved drug Vorinostat on PDAC spheroids.

4ATHANA Alliance Partners (SmartDyeLivery, Jena Bioscience, BioControl Jena, Hapila, Dyomics, Leibniz-HKI, Jena University Hospital)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-07-05
Description

RUBIN Alliance (ATHANA - antifungal therapy approaches with nanoparticle-based targeting) developing innovative therapeutic approaches for infectious diseases, particularly fungal infections. BMBF funding of almost 6 million euros over three years. Dynamic42 contributes organ-on-chip models for infection research. Alliance covers entire value chain for nanoparticle-based pharmaceutical development.

dynamic42.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Funded project investigating pharmacokinetic properties of drugs in a biochip-based liver organ model. Analysis of recycling, viability and vascular permeability of two frequently used monoclonal antibodies (mAbs). Initial results presented at MPS World Summit and EUROoCS annual meeting.

6Axon Lab AG
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partner for Switzerland, Slovakia, Slovenia, Poland, and Croatia handling product requests for Dynamic42's organ-on-chip products and systems.

dynamic42.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partner for the United States and Canada handling product requests for Dynamic42's organ-on-chip products and systems.

8MPSlabs
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration on multi-organ-on-chip model for improving drug safety during pregnancy. Joint webinar and development of interactive computational software to understand blood-placenta-barrier crossing.

dynamic42.com
9Wolfgang Kintzel (Strategic Advisor)
Strategic tierCoreTypeOthers
Description

International experienced manager with over 35 years in Life Sciences industry. Engaged as strategic advisor to support business model scaling and planned U.S. market entry. Previously served as Sparring partner for strategic questions on product positioning, commercialization, and internationalization.

dynamic42.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Dutch organ-on-chip company offering the OrganoPlate platform for 3D tissue models and high-throughput screening. Closest direct competitor in European microphysiological systems and a fellow IAMPS founding member.

TypeDirect peer
Description

Swiss provider of 3D organ-on-chip and organoid models for drug discovery and toxicology, with strong pharma services revenue. Another IAMPS founding member and direct head-to-head competitor in European MPS.

TypeDirect peer
Description

Berlin-based organ-on-chip company focused on multi-organ (MOC) and HUMIMIC platforms. Same geographic base as Dynamic42, fellow IAMPS founding member, and competes on multi-organ-chip applications.

TypeDirect peer
Description

US-based organ-on-chip leader (founded out of Wyss Institute) offering the Organ-Chip platform and Human Emulation System. Larger, better-capitalized competitor addressing the same pharma customer base.

5CN Bio
TypeDirect peer
Description

UK-based organ-on-chip company offering the PhysioMimix platform for single- and multi-organ models, with strong pharma and CRO partnerships. Directly comparable product positioning and customer base.

TypeDirect peer
Description

Swiss lung-on-chip specialist serving respiratory disease modeling, drug discovery, and inhalation toxicology. Fellow IAMPS founding member with narrower organ focus.

TypeDirect peer
Description

French organ-on-chip company providing microfluidic devices for neuro-inflammation and industrial applications. Fellow IAMPS founding member with overlapping pharma/biotech customer base.

TypeDirect peer
Description

Italian organ-on-chip company focused on immune-competent disease models using proprietary uBeat platform. Fellow IAMPS founding member with similar immunocompetence angle.

9Kirkstall
TypeDirect peer
Description

UK-based organ-on-chip company offering the Quasi Vivo multi-organ flow system for ADMET and toxicology. Competes in adjacent organ-on-chip platforms for pharma research.

TypeDirect peer
Description

Italian organ-on-chip company providing the MIVO (Multi-In Vitro Organ) platform for drug testing. Fellow IAMPS founding member with overlapping pharma services and 3D tissue model offerings.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dynamic42

Organ-on-chip Technologydynamic42.com

Dynamic42 GmbH develops and sells immunocompetent organ-on-chip platforms (DynamicOrgan® System) and provides contract research services to pharmaceutical, biotech, and academic customers for preclinical drug testing, toxicology, and human disease modeling.

What Dynamic42 does

Dynamic42 GmbH is a German biotechnology company founded in 2018 as a spin-off from the Integrated Research and Treatment Center for Sepsis Control and Care (CSCC) at the University Hospital Jena. The company develops and commercializes immunocompetent organ-on-chip (microfluidic biochip) in vitro test systems that replicate key functions of human organs, including vasculature, immune cells, microbiome, and pathogens, for preclinical drug testing, toxicology, and disease modeling applications.

The company's core platform is the DynamicOrgan® System, a modular organ-on-chip architecture featuring biochips with low compound adsorption, integrated pumps, and a portfolio of add-on kits: 2-Channel, 3-Channel, Spheroid, Tumor Microenvironment (TME), TEER-Sensor (embedded gold electrodes for barrier integrity), and O2-Sensor (developed with PyroScience) kits. The platform supports multiple organ models (gut, liver, lung, vasculature, cancer, spheroid) and multi-organ configurations such as gut-liver axis. Manufacturing and services operate under ISO 9001 and ISO 13485 quality standards, and Dynamic42 is a founding member of IAMPS, Europe's first industry association for microphysiological systems providers.

Dynamic42 generates revenue through three streams: (1) hardware sales of the DynamicOrgan System and modular kits, (2) fee-for-service Contract Research (CRO) offerings including toxicology screenings, lead identification/optimization, and custom in vitro model development, and (3) the Dynamic42 Academy training programs for organ-on-chip users. The customer base spans pharmaceutical and chemical companies (BASF, Sanofi via iDEA-iTECH Award, Bayer Consumer Health), academic and research institutions (Jena University Hospital, Leibniz-HKI, HZI Braunschweig, MLU Halle-Wittenberg, Freie Universität Berlin), and CROs. Distribution combines direct sales from Jena headquarters with regional distributors (Axon Lab AG for Central Europe, Ohio Lumex for the U.S./Canada) as the company expands internationally, including a planned U.S. market entry supported by a mid-seven-figure Series A round closed in June 2023.

Dynamic42 firmographics

Firmographics
Name
Dynamic42
Legal name
Dynamic42 GmbH
Website
https://dynamic42.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Dynamic42 GmbH develops and sells immunocompetent organ-on-chip platforms (DynamicOrgan® System) and provides contract research services to pharmaceutical, biotech, and academic customers for preclinical drug testing, toxicology, and human disease modeling.
Ownership category
akta.pro rank

Dynamic42 industry classification

Industry
Product category
Organ-on-chip Technology
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAAAGAD
Organoids & Organ-on-Chip (regenerative models)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Organ-on-chip technology
  • Microphysiological systems
  • In vitro disease models
  • Preclinical drug testing
  • Biotech research tools

Where Dynamic42 is headquartered

Location

Headquarters

HQ city
Jena
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Dynamic42 business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain, Others

Revenue model

  1. DynamicOrgan System and Kits Sales: Sale of the DynamicOrgan System platform, biochips, and various developer, sensor, and reagent kits including 2-Channel Kit, 3-Channel Kit, Spheroid Kit, TME Kit, TEER-Sensor Kit, and O2-Sensor Kit.
  2. Contract Research Services (CRO): Fee-for-service offerings including toxicology screenings, lead identification and optimization, and custom in vitro model development using the company's organ-on-chip platforms.
  3. Dynamic42 Academy Training: On-site and online training courses through the Dynamic42 Academy for researchers wanting to integrate organ-on-chip technology into their lab work.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Dynamic42 product offering

Product offering

Core offering

Dynamic42 develops and sells the DynamicOrgan® System, an organ-on-chip (microfluidic biochip) platform with modular kits (2-Channel, 3-Channel, Spheroid, TME, TEER-Sensor, O2-Sensor) that recreate human organ functions including vascularization, immune cells, microbiome, and pathogens. The company also offers fee-for-service contract research (toxicology screenings, lead optimization, custom model development) and training via the Dynamic42 Academy to pharmaceutical, biotech, and academic customers.

Product overview

Dynamic42 offers the DynamicOrgan® System as its core platform for organ-on-chip technology, accompanied by a modular kit portfolio including 2-Channel, 3-Channel, Spheroid, TME (Tumor Microenvironment), TEER-Sensor, and O2-Sensor kits. These kits are designed to work with the DynamicOrgan® System to create various organ models (Gut, Liver, Lung, Vasculature, Spheroid, Cancer-on-Chip). The platform is designed for immunocompetent infection and disease models with vascularization and organ-specific perfusion capabilities. The company also provides Contract Research Services for toxicology screenings, lead optimization, and custom model development, along with Dynamic42 Academy training programs.

Differentiator

Problem solved

Functional benefit

Brands

  • DynamicOrgan® System: User-friendly organ-on-chip system with ISO-certified, medical-grade standards for creating diverse organ models including gut, lung, liver, vasculature, cancer, and spheroid-on-chip.

Products and services

  • DynamicOrgan® System Core organ-on-chip platform that enables physiological cell and tissue culture. The system includes biochips and a pump that integrate seamlessly into existing workflows for creating human disease and infection models with vascularization, immune cells, microbiome, and pathogens. Sold to pharmaceutical, biotech, and academic researchers.
  • DynamicOrgan® 2-Channel Kit Biochip kit with two channels for creating in vitro human disease and infection models in a dynamically perfused environment, sold separately to laboratories building organ-on-chip models.
  • DynamicOrgan® 2-Channel Kit – precious Specialized version of the 2-channel kit designed for working with precious or limited cell samples; sold as a standalone SKU.
  • DynamicOrgan® 3-Channel Kit Three-channel biochip kit that enables more complex multi-layer tissue models and co-culture setups, sold as a standalone product for advanced organ-on-chip applications.
  • DynamicOrgan® Spheroid Kit Kit designed for spheroid culture within the DynamicOrgan System, enabling 3D tumor and tissue model development. Sold to researchers building 3D spheroid-on-chip applications.
  • DynamicOrgan® TME Kit Tumor Microenvironment Kit for cancer research, enabling biomimetic matrix integration in 3-channel biochips for advanced cancer models with stromal and immune components.
  • DynamicOrgan® TEER-Sensor Kit Sensor kit enabling integrated Trans-Epithelial/Trans-Endothelial Electrical Resistance (TEER) measurement, with embedded gold electrodes for real-time, non-invasive barrier integrity monitoring within the biochip architecture.
  • DynamicOrgan® O2-Sensor Kit Sensor kit for real-time oxygen tracking in organ-on-chip models, developed in collaboration with PyroScience, enabling monitoring of oxygen levels experienced by cells in the microfluidic environment.
  • Contract Research Services Fee-for-service contract research offerings including toxicology screenings, lead identification and optimization, and custom in vitro model development using Dynamic42's immune-competent organ models; offered directly to pharmaceutical, biotech, and chemical customers.
  • Dynamic42 Academy Training program offering on-site and online courses for learning organ-on-chip technology, including chip handling, cell culture, and organ model development. Available to researchers integrating organ-on-chip technology into their laboratory work.

Quantifiable outcome

  • Verifying recycling process of therapeutic antibodies without compromising cell viability or tissue integrity in liver-on-chip model
  • +2 more outcomes

Companies that use Dynamic42

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Dynamic42 technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Dynamic42 partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • EPO Experimental Pharmacology & Oncology Berlin-Buch GmbHcoreStrategic or Co-development Partner · 8 April 2026Strategic collaboration to integrate organ-on-chip technologies into preclinical glioblastoma research. First joint projects target glioblastoma and blood-brain barrier (BBB) using Dynamic42's human-based BBB-on-chip model. The partnership includes model development, commercialization strategies, and scientific exchange between researchers from both organizations. Joint presentation at AACR Annual Meeting 2026.
  • IAMPS (Industry Alliance for Microphysiological Systems)coreStrategic or Co-development Partner · 10 February 2026World's first industry association dedicated to representing microphysiological systems providers across Europe. Founding member along with Alveolix, BiomimX, Chiron, InSphero, MIMETAS, NETRI, React4Life, and TissUse. IAMPS will work to increase regulatory acceptance of MPS data, create data-sharing platforms, and advance device standardization. Expected to become operational Q2 2026.
  • Heinrich Heine University Düsseldorf (Institute of Pharmaceutical Biology and Biotechnology)coreStrategic or Co-development Partner · 6 March 2025Collaboration to develop tumour-on-chip model replicating pancreatic ductal adenocarcinoma (PDAC) microenvironment. Joint research with Prof. Dr. Nicole Teusch's team. Results published in Lab on a Chip journal. Model tested FDA-approved drug Vorinostat on PDAC spheroids.
  • ATHANA Alliance Partners (SmartDyeLivery, Jena Bioscience, BioControl Jena, Hapila, Dyomics, Leibniz-HKI, Jena University Hospital)coreStrategic or Co-development Partner · 5 July 2023RUBIN Alliance (ATHANA - antifungal therapy approaches with nanoparticle-based targeting) developing innovative therapeutic approaches for infectious diseases, particularly fungal infections. BMBF funding of almost 6 million euros over three years. Dynamic42 contributes organ-on-chip models for infection research. Alliance covers entire value chain for nanoparticle-based pharmaceutical development.
  • Sanofi (iDEA-iTECH Award Program)coreStrategic or Co-development Partner · 1 January 2023Funded project investigating pharmacokinetic properties of drugs in a biochip-based liver organ model. Analysis of recycling, viability and vascular permeability of two frequently used monoclonal antibodies (mAbs). Initial results presented at MPS World Summit and EUROoCS annual meeting.
  • Axon Lab AGcoreChannel Partner/ Reseller/ DistributorRegional distribution partner for Switzerland, Slovakia, Slovenia, Poland, and Croatia handling product requests for Dynamic42's organ-on-chip products and systems.
  • Ohio LumexcoreChannel Partner/ Reseller/ DistributorRegional distribution partner for the United States and Canada handling product requests for Dynamic42's organ-on-chip products and systems.
  • MPSlabsminorStrategic or Co-development PartnerCollaboration on multi-organ-on-chip model for improving drug safety during pregnancy. Joint webinar and development of interactive computational software to understand blood-placenta-barrier crossing.
  • Wolfgang Kintzel (Strategic Advisor)coreOthersInternational experienced manager with over 35 years in Life Sciences industry. Engaged as strategic advisor to support business model scaling and planned U.S. market entry. Previously served as Sparring partner for strategic questions on product positioning, commercialization, and internationalization.

Scale indicators5 records

Recent moves7 records

Expansion highlights7 records

Dynamic42 competitors and assessment

Company assessment

Direct peers

  • MIMETAS: Dutch organ-on-chip company offering the OrganoPlate platform for 3D tissue models and high-throughput screening. Closest direct competitor in European microphysiological systems and a fellow IAMPS founding member.
  • InSphero: Swiss provider of 3D organ-on-chip and organoid models for drug discovery and toxicology, with strong pharma services revenue. Another IAMPS founding member and direct head-to-head competitor in European MPS.
  • TissUse: Berlin-based organ-on-chip company focused on multi-organ (MOC) and HUMIMIC platforms. Same geographic base as Dynamic42, fellow IAMPS founding member, and competes on multi-organ-chip applications.
  • Emulate: US-based organ-on-chip leader (founded out of Wyss Institute) offering the Organ-Chip platform and Human Emulation System. Larger, better-capitalized competitor addressing the same pharma customer base.
  • CN Bio: UK-based organ-on-chip company offering the PhysioMimix platform for single- and multi-organ models, with strong pharma and CRO partnerships. Directly comparable product positioning and customer base.
  • Alveolix: Swiss lung-on-chip specialist serving respiratory disease modeling, drug discovery, and inhalation toxicology. Fellow IAMPS founding member with narrower organ focus.
  • NETRI: French organ-on-chip company providing microfluidic devices for neuro-inflammation and industrial applications. Fellow IAMPS founding member with overlapping pharma/biotech customer base.
  • BiomimX: Italian organ-on-chip company focused on immune-competent disease models using proprietary uBeat platform. Fellow IAMPS founding member with similar immunocompetence angle.
  • Kirkstall: UK-based organ-on-chip company offering the Quasi Vivo multi-organ flow system for ADMET and toxicology. Competes in adjacent organ-on-chip platforms for pharma research.
  • React4Life: Italian organ-on-chip company providing the MIVO (Multi-In Vitro Organ) platform for drug testing. Fellow IAMPS founding member with overlapping pharma services and 3D tissue model offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Dynamic42 social profiles

Digital presence

Dynamic42 compliance and trust

Trust signal

Compliance2 records

Dynamic42 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dynamic42 leadership team

Management profile

Number of profiles

Profiles5 records

Dynamic42 funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dynamic42 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dynamic42

What does Dynamic42 do?

Dynamic42 develops and sells the DynamicOrgan® System, an organ-on-chip (microfluidic biochip) platform with modular kits (2-Channel, 3-Channel, Spheroid, TME, TEER-Sensor, O2-Sensor) that recreate human organ functions including vascularization, immune cells, microbiome, and pathogens. The company also offers fee-for-service contract research (toxicology screenings, lead optimization, custom model development) and training via the Dynamic42 Academy to pharmaceutical, biotech, and academic customers.

Is Dynamic42 a public or private company?

Dynamic42 is a private company. It is classified as venture growth investor backed and is currently operating.

When was Dynamic42 founded?

Dynamic42 was founded in 2018. It employs 11 to 50 people.

Where is Dynamic42 based?

Dynamic42 is headquartered in Jena, Germany, in the Europe region.

How does Dynamic42 make money?

Three revenue lines are on record. DynamicOrgan System and Kits Sales are the primary driver. The others are contract Research Services (CRO) and dynamic42 Academy Training.

Who are Dynamic42's main competitors?

Direct peers on record are MIMETAS, InSphero, TissUse, Emulate, CN Bio, Alveolix, NETRI, BiomimX, Kirkstall and React4Life.

Does Dynamic42 have an API?

No public API is recorded for Dynamic42.

What industry is Dynamic42 in?

Dynamic42's product category is Organ-on-chip Technology. Its primary akta.pro industry code is HLAAAGAD, Organoids & Organ-on-Chip (regenerative models), with a secondary code of HLAAAIAJ, In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems). Its NAICS code is 541714 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GenengnewsOrgan-on-Chip Integrated Into Preclinical Glioblastoma ResearchDynamic42 and EPO formed a strategic collaboration to integrate organ-on-chip technologies into preclinical glioblastoma research. The partnership uses Dynamic42's BBB-on-chip model to study human tumor biology and blood-brain barrier differences, aiming to improve drug translation. First results will be presented at the AACR Annual Meeting 2026.EIN PresswireIndustry Leaders Announce World’s First Microphysiological Systems Industry Association (IAMPS)European MPS industry leaders announced the creation of the Industry Alliance for Microphysiological Systems (IAMPS), the world's first industry association dedicated to representing microphysiological systems providers across Europe. The founding members include nine companies: Alveolix, BiomimX, Chiron, Dynamic42, InSphero, MIMETAS, NETRI, React4Life, and TissUse, headquartered in Switzerland, Italy, the Netherlands, Germany, and France. IAMPS will work to increase regulatory acceptance of MPS data, create data-sharing platforms, and advance device standardization, with the association expected to become operational in Q2 2026.YahooTumour-on-chip model could help discover pancreatic cancer therapiesGerman scientists and biotech Dynamic42 developed a tumour-on-chip model of pancreatic ductal adenocarcinoma to study drug efficacy. The chip, tested with FDA-approved vorinostat, killed cancer spheroids without damaging vascular integrity. The model aims to improve preclinical drug testing and reduce reliance on animal models.News-MedicalNew three-organ system offers an animal-free alternative for pharmacokinetics researchDynamic42 and ESQlabs developed a three-organ organ-on-chip system with Bayer and Jena University Hospital to simulate drug pharmacokinetics in pregnant women. The system, tested with prednisone, aims to reduce animal testing and improve drug safety predictions. Results were published in Frontiers in Pharmacology.Dynamic42Dynamic42 raises mid-seven-figure investment in financing roundDynamic42 GmbH, a Jena-based biotechnology company specializing in organ-on-chip technology, has closed a mid-seven-figure Series A financing round. The investment was led by previous investor bm-t beteiligungsmanagement thüringen gmbh and a health sector family office to support the company's growth and international expansion. This funding will be used to further develop products, expand sales infrastructure, and enter the US pharmaceutical market.